The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Role of proliferation in response to neoadjuvant chemotherapy in GEICAM/2006-03 and GEICAM/2006-14 breast cancer patients.
E. Alba
No relevant relationships to disclose
Joan Albanell
No relevant relationships to disclose
Jose Ignacio Chacon Lopez-Muniz
No relevant relationships to disclose
Lourdes Calvo
No relevant relationships to disclose
Juan De la Haba- Rodriguez
No relevant relationships to disclose
Pedro Sanchez Rovira
No relevant relationships to disclose
Arrate Plazaola
No relevant relationships to disclose
Agust Barnadas
No relevant relationships to disclose
Miguel Angel Seguí-Palmer
No relevant relationships to disclose
Angels Arcusa Lanza
No relevant relationships to disclose
Manuel Ramos Vazquez
No relevant relationships to disclose
Federico Rojo
No relevant relationships to disclose
Octavio Burgues
No relevant relationships to disclose
Bella Pajares
No relevant relationships to disclose
Begoña Bermejo
No relevant relationships to disclose
Alfonso Sanchez-Muñoz
No relevant relationships to disclose
Maria Isabel Casas
No relevant relationships to disclose
Rosalia Caballero
No relevant relationships to disclose
Eva Maria Carrasco
No relevant relationships to disclose
Ana Lluch
No relevant relationships to disclose